Anesthesia 1
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Powering Your Performance
POWERING YOUR PERFORMANCE B105M | B125M | B155M Modular Patient Monitors gehealthcare.com Advanced capabilities. Simple scalability. Dependable technology. B1x5M range of modular patient monitors deliver premium clinical performance across care areas. Scalable platform You can monitor essential vital signs (ECG, SpO2, Temp, NIBP, RR) and easily scale to advanced parameter modules like respiratory gases and Clinical precision anesthetic agents, NMT and Entropy™ – up to three advanced parameters simultaneously. These accurate, reliable, and easy-to-use monitors Intuitive design enable simple and intuitive workflow with a choice of 10-, 12- or 15-inch touch screen displays. B1x5M range of monitors come with Value Dependable technology Software Platform (VSP 3.0). Legacy of premium clinical performance. Excellence of advanced features. Timely clinical decisions. GE Healthcare’s more than 45 years of clinical excellence in The B1x5M range of modular patient monitors helps you quickly designing reliable patient monitoring systems provides you with take charge of patient conditions like arrhythmia and high/low advanced features, such as: blood pressure, and efficiently assess the level of consciousness. They seamlessly integrate with the CARESCAPE Ecosystem for centralized alarm management and efficient workflow. • DINAMAP™ SuperSTAT™ NIBP • EK-Pro v14 algorithm The solutions allow you to effectively monitor deteriorating • CO sidestream and cardiac output patient conditions and make timely interventions by tracking the 2 National Early Warning -
Effects of Prophylactic Ketamine and Pethidine to Control Postanesthetic Shivering: a Comparative Study
Biomedical Research and Therapy, 5(12):2898-2903 Original Research Effects of prophylactic ketamine and pethidine to control postanesthetic shivering: A comparative study Masoum Khoshfetrat1, Ali Rosom Jalali2, Gholamreza Komeili3, Aliakbar Keykha4;∗ ABSTRACT Background: Shivering is an undesirable complication following general anesthesia and spinal anesthesia, whose early control can reduce postoperative metabolic and respiratory complications. Therefore, this study aims to compare the effects of prophylactic injection of ketamine and pethi- dine on postoperative shivering.Methods: This double-blind clinical trial was performed on 105 patients with short-term orthopedic and ENT surgery. The patients were randomly divided into three groups; 20 minutes before the end of the surgery, 0.4 mg/kg of pethidine was injected to the first group, 0.5 mg/kg of ketamine was injected to the second group, and normal saline was injected to the third group. After the surgery, the tympanic membrane temperature was measured at 0, 10, 20, and 30 minutes. The shivering was also measured by a four-point grading from zero (no shiv- ering) to four (severe shivering). Data were analyzed by one-way ANOVA, Kruskal Wallis, Chi-square 1Doctor of Medicine (MD), Fellow of and Pearson correlation. Results: The mean age of patients was 35.811.45 years in the ketamine Critical Care Medicine (FCCM), group, 34.811.64 years in the normal saline group, and 33.1110.5 years in the pethidine group. Department of Anesthesiology and The one-way ANOVA showed no significant difference in the mean age between the three groups Critical Care, Khatam-Al-Anbiya (P=0.645). -
Pain Management
BLBK137-Paul February 20, 2009 13:17 CHAPTER 8 8 Pain management Mark Nichols MD, Glenna Halvorson-Boyd PhD, RN, Robert Goldstein MD, Clifford Gevirtz MD, MPH and David Healow MD LEARNING POINTS r Proper selection of medications and nonpharmacological interventions reduces pain and anxiety and enhances patient satisfaction. r Several effective techniques exist for administration of local cervical anesthesia. Limited data support use of deep injections and adjunctive premedication with nonsteroidal antiinflammatory drugs. r The most common conscious sedation regimen used by North American abortion providers is a combination of fentanyl and midazolam. r Deep sedation and general anesthesia carry important benefits for certain patients, but they require specialized personnel and equipment. Introduction Pain associated with abortion Managing pain associated with abortion procedures is an es- Pain management remains an important challenge in abor- sential goal in the care of patients requesting pregnancy ter- tion practice, although studies suggest that progress in pain mination. Effective methods range from local cervical anes- control has been achieved over time in the USA. In a sur- thesia, with or without supplemental oral or intravenous vey in the late 1970s, 2,299 women having abortions with (IV) medications, to general anesthesia (GA). A number cervical anesthesia were asked to rate their pain as “mild, of factors influence the options available to patients, in- moderate, or severe.” Forty-six per cent called the pain mod- cluding local regulations, safety considerations, facility in- erate, and 32% called it severe. [2] A survey conducted two frastructure and resources, cost, and insurance coverage. decades later of more than 2,000 patients at 12 abortion fa- In the USA, where most abortions occur in freestanding cilities in the USA found that 30% of patients felt no pain, clinics, cervical anesthesia with or without IV conscious 25% mild pain, 29% moderate pain, and 14% severe pain. -
Perioperative Opioid Administration
REVIEW ARTICLE Deborah J. Culley, M.D., Editor ABSTRACT Opioids form an important component of general anesthesia and periopera- tive analgesia. Discharge opioid prescriptions are identified as a contributor for persistent opioid use and diversion. In parallel, there is increased enthu- Perioperative Opioid siasm to advocate opioid-free strategies, which include a combination of known analgesics and adjuvants, many of which are in the form of continuous Administration infusions. This article critically reviews perioperative opioid use, especially in view of opioid-sparing versus opioid-free strategies. The data indicate that A Critical Review of Opioid-free versus opioid-free strategies, however noble in their cause, do not fully acknowledge the limitations and gaps within the existing evidence and clinical practice con- Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/134/4/645/512461/20210400.0-00024.pdf by guest on 24 September 2021 Opioid-sparing Approaches siderations. Moreover, they do not allow analgesic titration based on patient needs; are unclear about optimal components and their role in different sur- Harsha Shanthanna, M.D., Ph.D., F.R.C.P.C., gical settings and perioperative phases; and do not serve to decrease the Karim S. Ladha, M.D., M.Sc., F.R.C.P.C., risk of persistent opioid use, thereby distracting us from optimizing pain and Henrik Kehlet, M.D., Ph.D., minimizing realistic long-term harms. Girish P. Joshi, M.B.B.S., M.D., F.F.A.R.C.S.I. (ANESTHESIOLOGY 2021; 134:645–59) ANESTHESIOLOGY 2021; 134:645–59 At the same time, this seems to have precipitated a pioids are an integral part of perioperative care rethinking around the use of opioids during the periop- Obecause of their high analgesic efficacy.1–3 They have erative period, and anesthesiologists are identifying the well-known short-term adverse effects and the potential role they can play in decreasing the burden of the opioid for long-term adverse effects for patients and society.3–5 crisis. -
Effect of Local Infiltration Analgesia, Peripheral Nerve Blocks, General
Berninger et al. BMC Musculoskeletal Disorders (2018) 19:232 https://doi.org/10.1186/s12891-018-2154-z RESEARCHARTICLE Open Access Effect of local infiltration analgesia, peripheral nerve blocks, general and spinal anesthesia on early functional recovery and pain control in total knee arthroplasty M. T. Berninger1,2* , J. Friederichs2, W. Leidinger3, P. Augat4,5, V. Bühren2, C. Fulghum1 and W. Reng1 Abstract Background: Postoperative pain control and enhanced mobilization, muscle strength and range of motion following total knee arthroplasty (TKA) are pivotal requisites to optimize rehabilitation and early recovery. The aim of the study was to analyze the effect of local infiltration analgesia (LIA), peripheral nerve blocks, general and spinal anesthesia on early functional recovery and pain control in primary total knee arthroplasty. Methods: Between January 2016 until August 2016, 280 patients underwent primary TKA and were subdivided into four groups according to their concomitant pain and anesthetic procedure with catheter-based techniques of femoral and sciatic nerve block (group GA&FNB, n = 81) or epidural catheter (group SP&EPI, n = 51) in combination with general anesthesia or spinal anesthesia, respectively, and LIA combined with general anesthesia (group GA&LIA, n = 86) or spinal anesthesia (group SP&LIA, n = 61). Outcome parameters focused on the evaluation of pain (NRS scores), mobilization, muscle strength and range of motion up to 7 days postoperatively. The cumulative consumption of (rescue) pain medication was analyzed. Results: Pain relief was similar in all groups, while the use of opioid medication was significantly lower (up to 58%) in combination with spinal anesthesia, especially in SP&EPI. -
Using Entropy in the General Anesthesia Managements
Research Article Clinics in Surgery Published: 07 Jul, 2017 Using Entropy in the General Anesthesia Managements Elif Büyükerkmen, Remziye Gül Sivaci and Elif Doğan Baki* Departement of Anesthesiology and Reanimation, Afyon Kocatepe University, Afyonkarahisar, Turkey Abstract Purpose: We aimed to investigate the effects of three general anesthesic management on depth of anesthesia, anesthesic quality, agent consumption and postoperative recovery. Materials and Methods: 90 patients scheduled for elective tympanoplasty and septoplasty surgery with American Society of Anesthesiologist (ASA) pysical status between I-III were included in this study. Neuromuscular transmission (NMT), surgical pleth index (SPI) and entropy were monitorized in addition to standart monitoring. Entropy was recorded as state entropy (SE) and response entropy (RE). After standart anesthesia induction, patients were divided into three groups according to maintenance of anesthesia using a sealed envelope system. Propofol 3-5 mg/kg/h iv infusion was performed to Group 1 (Group P, n=30), Desflurane 1MAC was used to Group 2 (Group D, n=30) and Sevoflurane to Group 3 (Group S, n=30). Also, rocuronium and remifentanyl infusion were used in maintenance. While desflurane and sevoflurane consumption were recorded from the anesthesia directly, propofol consumption was calculated through the consumption of perfusors and recorded at the end of the surgery. Total cost of anesthetics that used were calculated by multiplying the unit price with their consumption. Apart from these, hemodynamic values of all patients, recovery time, alertness levels in the recovery room (according to Ramsey Scale) were recorded. Results: Significant differences were found between the three groups in terms of cost. While the cost of propofol was significantly lower, it was significantly higher in desfluane group. -
Effect of Rutin on Gentamicin-Induced Ototoxicity in Rats: a Biochemical and Histopathological Examination
ORIGINAL ARTICLE ENT UPDATES 11(1):8-13 DOI: 10.5152/entupdates.2021.887158 Effect of Rutin on Gentamicin-Induced Ototoxicity in Rats: A Biochemical and Histopathological Examination Abstract Objective: Gentamicin is a broad-spectrum aminoglycoside antibiotic administered parenterally for moderate to severe gram-negative infections. Ototoxicity is an im- portant side effect that limits gentamicin use. The aim of this study is to investigate the effect of rutin on gentamicin-induced ototoxicity in rats biochemically and histo- pathologically. Methods: Distilled water was administered by oral gavage to healthy controls (HG) and cobalt administered group (GC). 50 mg/kg rutin was administered by oral gavage to rutin + gentamicin (RGG) group. After one hour, 100 mg/kg gentamicin was injected intraperitoneally (i.p) to the RGG and GC animal groups. This procedure was repeated once a day for 14 days. Results: Malondialdehyde (MDA), nuclear factor-κB(NF-κB), tumor necrosis factor alpha (TNF-α) and interleukin-1 beta(IL-1β) levels in the cochlear nerve tissue of gen- tamicin-treated animals were significantly higher compared to healthy controls and rutin + gentamicin treated rats. On the other hand, the amount of total Glutathione (tGSH) was significantly lower compared to the control and rutin group. Histopatho- logical examination revealed degenerated myelinated nerve fibers in the gentamicin group and Schwann cell nuclei were generally not seen. There was a high accumula- tion of collagen fiber in the tissue and dilated blood capillaries. In the rutin group, my- elinated nerve fibers mostly exhibited normal morphology, Schwann cell nuclei were İsmail Salcan1 evident and the vessels were normal. -
General Anesthesia and Altered States of Arousal: a Systems Neuroscience Analysis
General Anesthesia and Altered States of Arousal: A Systems Neuroscience Analysis The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Brown, Emery N., Patrick L. Purdon, and Christa J. Van Dort. “General Anesthesia and Altered States of Arousal: A Systems Neuroscience Analysis.” Annual Review of Neuroscience 34, no. 1 (July 21, 2011): 601–628. As Published http://dx.doi.org/10.1146/annurev-neuro-060909-153200 Publisher Annual Reviews Version Author's final manuscript Citable link http://hdl.handle.net/1721.1/86331 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ NIH Public Access Author Manuscript Annu Rev Neurosci. Author manuscript; available in PMC 2012 July 06. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Annu Rev Neurosci. 2011 ; 34: 601–628. doi:10.1146/annurev-neuro-060909-153200. General Anesthesia and Altered States of Arousal: A Systems Neuroscience Analysis Emery N. Brown1,2,3, Patrick L. Purdon1,2, and Christa J. Van Dort1,2 Emery N. Brown: [email protected]; Patrick L. Purdon: [email protected]; Christa J. Van Dort: [email protected] 1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114 2Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 3Harvard-MIT Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 Abstract Placing a patient in a state of general anesthesia is crucial for safely and humanely performing most surgical and many nonsurgical procedures. -
Aldrich Raman
Aldrich Raman Library Listing – 14,033 spectra This library represents the most comprehensive collection of FT-Raman spectral references available. It contains many common chemicals found in the Aldrich Handbook of Fine Chemicals. To create the Aldrich Raman Condensed Phase Library, 14,033 compounds found in the Aldrich Collection of FT-IR Spectra Edition II Library were excited with an Nd:YVO4 laser (1064 nm) using laser powers between 400 - 600 mW, measured at the sample. A Thermo FT-Raman spectrometer (with a Ge detector) was used to collect the Raman spectra. The spectra were saved in Raman Shift format. Aldrich Raman Index Compound Name Index Compound Name 4803 ((1R)-(ENDO,ANTI))-(+)-3- 4246 (+)-3-ISOPROPYL-7A- BROMOCAMPHOR-8- SULFONIC METHYLTETRAHYDRO- ACID, AMMONIUM SALT PYRROLO(2,1-B)OXAZOL-5(6H)- 2207 ((1R)-ENDO)-(+)-3- ONE, BROMOCAMPHOR, 98% 12568 (+)-4-CHOLESTEN-3-ONE, 98% 4804 ((1S)-(ENDO,ANTI))-(-)-3- 3774 (+)-5,6-O-CYCLOHEXYLIDENE-L- BROMOCAMPHOR-8- SULFONIC ASCORBIC ACID, 98% ACID, AMMONIUM SALT 11632 (+)-5-BROMO-2'-DEOXYURIDINE, 2208 ((1S)-ENDO)-(-)-3- 97% BROMOCAMPHOR, 98% 11634 (+)-5-FLUORODEOXYURIDINE, 769 ((1S)-ENDO)-(-)-BORNEOL, 99% 98+% 13454 ((2S,3S)-(+)- 11633 (+)-5-IODO-2'-DEOXYURIDINE, 98% BIS(DIPHENYLPHOSPHINO)- 4228 (+)-6-AMINOPENICILLANIC ACID, BUTANE)(N3-ALLYL)PD(II) CL04, 96% 97 8167 (+)-6-METHOXY-ALPHA-METHYL- 10297 ((3- 2- NAPHTHALENEACETIC ACID, DIMETHYLAMINO)PROPYL)TRIPH 98% ENYL- PHOSPHONIUM BROMIDE, 12586 (+)-ANDROSTA-1,4-DIENE-3,17- 99% DIONE, 98% 13458 ((R)-(+)-2,2'- 963 (+)-ARABINOGALACTAN BIS(DIPHENYLPHOSPHINO)-1,1'- -
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2020) Revision 19 Annotated for Statistical Reporting Purposes PHARMACEUTICAL APPENDIX TO THE TARIFF SCHEDULE 2 Table 1. This table enumerates products described by International Non-proprietary Names INN which shall be entered free of duty under general note 13 to the tariff schedule. The Chemical Abstracts Service CAS registry numbers also set forth in this table are included to assist in the identification of the products concerned. For purposes of the tariff schedule, any references to a product enumerated in this table includes such product by whatever name known. -
(12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness Et Al
USOO6264,917B1 (12) United States Patent (10) Patent No.: US 6,264,917 B1 Klaveness et al. (45) Date of Patent: Jul. 24, 2001 (54) TARGETED ULTRASOUND CONTRAST 5,733,572 3/1998 Unger et al.. AGENTS 5,780,010 7/1998 Lanza et al. 5,846,517 12/1998 Unger .................................. 424/9.52 (75) Inventors: Jo Klaveness; Pál Rongved; Dagfinn 5,849,727 12/1998 Porter et al. ......................... 514/156 Lovhaug, all of Oslo (NO) 5,910,300 6/1999 Tournier et al. .................... 424/9.34 FOREIGN PATENT DOCUMENTS (73) Assignee: Nycomed Imaging AS, Oslo (NO) 2 145 SOS 4/1994 (CA). (*) Notice: Subject to any disclaimer, the term of this 19 626 530 1/1998 (DE). patent is extended or adjusted under 35 O 727 225 8/1996 (EP). U.S.C. 154(b) by 0 days. WO91/15244 10/1991 (WO). WO 93/20802 10/1993 (WO). WO 94/07539 4/1994 (WO). (21) Appl. No.: 08/958,993 WO 94/28873 12/1994 (WO). WO 94/28874 12/1994 (WO). (22) Filed: Oct. 28, 1997 WO95/03356 2/1995 (WO). WO95/03357 2/1995 (WO). Related U.S. Application Data WO95/07072 3/1995 (WO). (60) Provisional application No. 60/049.264, filed on Jun. 7, WO95/15118 6/1995 (WO). 1997, provisional application No. 60/049,265, filed on Jun. WO 96/39149 12/1996 (WO). 7, 1997, and provisional application No. 60/049.268, filed WO 96/40277 12/1996 (WO). on Jun. 7, 1997. WO 96/40285 12/1996 (WO). (30) Foreign Application Priority Data WO 96/41647 12/1996 (WO). -
Neuroanesthesia Checklists
Neuroanesthesia Checklists Contents: 1. Surgical resection of Arteriovenous Malformation (AVM) 2. Deep Brain Stimulation (DBS) 3. Flexible Endoscopic Intubation 4. Checklist: Prone Positioning Lumbar Spine Surgery 5. Moyamoya / Extra- Intracranial Bypass 6. Lidocaine Infusions for Trigeminal Nerve Neurolysis in Neuroradiology Suite 7. Checklist for Stroke – Endovascular Therapy 8. Craniotomy for Resection of Supratentorial Tumor 9. SNACC Neuroanesthetic Emergencies Critical Event Treatment Guides Surgical resection of Arteriovenous Malformation (AVM) Surgical characteristics Duration of surgery Variable. Between 6 to 12 hours. Expected blood loss Variable. Potential high blood loss during the procedure. Blood group confirmation is mandatory. Positioning Depending on the location of AVM Antibiotic therapy As per surgical protocol. Anesthesia Pre-Anesthesia Optimize pre-existing medical conditions. Review the size, location and characteristics of AVM. Was endovascular embolization performed prior to surgery? Mode of Anesthesia Usually general anesthesia. Consider TIVA (Propofol). Airway Standard management / avoid sympathetic response to laryngoscopy. Ventilation Normoventilation. Mild hyperventilation (paCO2 28-33 mmHg) may be indicated in selected cases. Target MAP Initially maintain normotension. Discuss BP management with surgeon, often deliberate hypotension needed. Blood Gases Perform frequently – and as needed to control pCO2. Temperature Maintain normothermia. Use Bear Hugger blankets. Avoid hyperthermia. Transfer Consider ICU for postoperative BP control Special Potential major blood loss during procedure. considerations Be prepared to provide deliberate hypotension. Consider e.g. Esmolol (1 mg/kg, 0.5 mg/kg/min infusion), Labetalol, Nitroglycerin infusion. Often intraoperative angiogram. Indocyanine green dye sometimes used. Patient monitoring and vascular access Patient monitoring Standard CAS monitoring. Peripheral IV access Minimal 2 peripheral IV lines, one suitable for rapid infusion.